834
Views
34
CrossRef citations to date
0
Altmetric
Original Articles

Review of Properties and Analytical Methods for the Determination of Norfloxacin

&
Pages 22-39 | Published online: 08 Feb 2016

References

  • Abdel-Hay, M. H.; Hassan, E. M.; Gazy, A. A.; Belal, T. S. Kinetic Spectrophotometric Analysis and Spectrofluorimetric Analysis of Ciprofloxacin Hydrochloride and Norfloxacin in Pharmaceutical Preparations Using 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl). J. Chin. Chem. Soc. 2008, 55(4), 818–827.
  • Alghasham, A. A.; Nahata, M. C. Trovafloxacin: A New Fluoroquinolone. Ann. Pharmacother. 1999, 33(1), 48–60.
  • Alnajjar, A.; AbuSeada, H. H.; Idris, A. M. Capillary Electrophoresis for the Determination of Norfloxacin and Tinidazole in Pharmaceuticals with Multi-Response Optimization. Talanta 2007b, 72(2), 842–846.
  • Alnajjar, A.; Idris, A. M.; AbuSeada, H. H. Development of a Stability-Indicating Capillary Electrophoresis Method for Norfloxacin and Its Inactive Decarboxylated Degradant. Microchem. J. 2007a, 87(1), 35–40.
  • Amin, A. S. Quantitation of Some Recently Introduced Antibacterial Drugs Using Sudan III as Chromogenic Reagent. Microchim. Acta 2000, 134(1–2), 89–94.
  • Amin, A. S.; El-Sayed, G. O.; Issa, Y. M. Utility of Certain π-Acceptors for the Spectrophotometric Determination of Norfloxacin. Analyst. 1995, 120, 1189–1193.
  • Amin, A. S.; Moustafa, M. E.; El-Dosoky, R. M. S. Spectrophotometric Determination of Some Fluoroquinolone Derivatives in Dosage Forms and Biological Fluids Using Ion-Pair Complex Formation. Anal. Lett. 2008, 41, 837–852.
  • Andriole, V. T. The Quinolones: Past, Present, and Future. Clin. Infect. Dis. 2005, 41(Suppl. 2), 13–119.
  • ANVISA. Consulta de Produtos: Medicamentos. http://www7.anvisa.gov.br/datavisa/consulta_produto/Medicamentos/frmConsulta- Medicamentos.asp (accessed 5/21/13).
  • Appelbaum, P. C.; Hunter, P. A. The Fluoroquinolone Antibacterials: Past, Present and Future Perspectives. Int. J. Antimicrob. Agents 2000, 16(1), 5–15.
  • Avadhanulu, A. B.; Mohan, Y. R.; Srinivas, J. S.; Anjaneyulu, Y. Spectrophotometric Estimation of Certain Fluoroquinolone Drugs in Their Pharmaceutical Dosage Forms Using Ammonium Reineckate Reagent. Indian Drugs 1999, 36(5), 296–300.
  • Ball, P. Adverse Drug Reactions: Implications for the Development of Fluoroquinolones. J. Antimicrob. Chemother. 2003, 51(Suppl. 1), 21–27.
  • Ball, P. New Fluoroquinolones: Real and Potential Roles. Curr. Infect. Dis. Rep. 1999, 1(5), 470–479.
  • Barbosa, J.; Fonrodona, G.; Marqués, I.; Butí, S.; Toro, I. Factor Analysis Applied to the Correlation between Dissociation Constants and Solvatochromic Parameters in Acetonitrile-Water Mixtures: I. Solvent Effects on Dissociation of Carboxylic Acid Groups in Some Diuretics, Quinolones, Buffers and Peptides. TrAC Trends Anal. Chem. 1997, 16(2), 104–111.
  • Bedor, D. C. G.; Gonçalves, T. M.; Bastos, L. L.; Souza, C. E. M.; Abreu, L. R. P.; Oliveira, E. J.; Santana, D. P. Development and Validation of a New Method for the Quantification of Norfloxacin by HPLC-UV and Its Application to a Comparative Pharmacokinetic Study in Human Volunteers. Braz. J. Pharm. Sci. 2007, 43(2), 231–238.
  • Bogialli, S.; D’Ascenzo, G.; Di Corcia, A.; Laganà, A.; Nicolardi, S. A Simple and Rapid Assay Based on Hot Water Extraction and Liquid Chromatography-Tandem Mass Spectrometry for Monitoring Quinolone Residues in Bovine Milk. Food Chem. 2008, 108(1), 354–360.
  • Bolon, M. K. The Newer Fluoroquinolones. Infect. Dis. Clin. North Am. 2009, 23(4), 1027–1051.
  • Bolon, M. K. The Newer Fluoroquinolones. Med. Clin. North Am. 2011, 95(4), 793–817.
  • Borcherding, S. M.; Stevens, R.; Nicholas, R. A.; Corley, C. R.; Self, T. Quinolones: A Practical Review of Clinical Uses, Dosing Considerations, and Drug Interactions. J. Fam. Pract. 1996, 42(1), 69–78.
  • British Pharmacopoeia 2014. Her Majesty's Stationery Office: London, 2014.
  • Chen, C.; Liu, X.; Wu, R. High-Performance Liquid Chromatographic Method for the Determination of Norfloxacin Glutamate and Glucuronate in Solid and Liquid Dosage Forms and Its Application to Stability Testing. J. Pharm. Biomed. Anal. 1993, 11(8), 717–721.
  • Chen, F. J.; Lo, H. J. Molecular Mechanisms of Fluoroquinolone Resistance. J. Microbiol. Immunol. Infect. 2003, 36(1), 1–9.
  • Chen, Y. H.; Ko, W. C.; Hsueh, P. R. The Role of Fluoroquinolones in the Management of Urinary Tract Infections in Areas with High Rates of Fluoroquinolone-Resistant Uropathogens. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31(8), 1699–1704.
  • Chenel, M.; Marchand, S.; Dupuis, A.; Lamarche, I.; Paquereau, J.; Pariat, C.; Couet, W. Simultaneous Central Nervous System Distribution and Pharmacokinetic/Pharmacodynamic Modelling of the Electroencephalogram Effect of Norfloxacin Administered at a Convulsant Dose in Rats. Br. J. Pharmacol. 2004, 142(2), 323–330.
  • Cheng, C. L.; Fu, C. H.; Chou, C. H. Determination of Norfloxacin in Rat Liver Perfusate Using Capillary Electrophoresis with Laser-Induced Fluorescence Detection. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 856(1–2), 381–385.
  • Chierentin, L.; Salgado, H. R. N. Development and Validation of a Simple, Rapid and Stability-Indicating High Performance Liquid Chromatography Method for Quantification of Norfloxacin in a Pharmaceutical Product. J. Chromatogr. Sep. Tech. 2013, 4(2), 171–175.
  • Chierentin, L.; Salgado, H. R. N. Performance Characteristics of UV and Visible Spectrophotometry Methods for Norfloxacin Determination in Tablets. J. Sci. Res. 2014, 6(3), 531–541.
  • Christian, J. S. The Quinolone Antibiotics. Infect. Dis. Update 1996, 3(3), 87–92.
  • Christodoulou, E. A.; Samanidou, V. F.; Papadoyannis, I. N. Validation of an HPLC-UV Method According to the European Union Decision 2002/657/EC for the Simultaneous Determination of 10 Quinolones in Chicken Muscle and Egg Yolk. J. Chromatogr. B 2007, 859(2), 246–255.
  • Córdoba-Borrego, M.; Córdoba-Díaz, M.; Bernabé, I.; Córdoba-Díaz, D. Determination of Norfloxacin by Fluorescence in the Presence of Different Antacids: Quantification of Analytical Interferences. J. Pharm. Biomed. Anal. 1996, 14, 977–982.
  • Córdoba-Borrego, M.; Córdoba-Díaz, M.; Córdoba-Díaz, D. Validation of a High Performance Liquid Chromatographic Method for the Determination of Norfloxacin and Its Application to Stability Studies (Photo-Stability Study of Norfloxacin). J. Pharm. Biomed. Anal. 1999, 18(6), 919–926.
  • Córdoba-Díaz, M.; Córdoba-Borrego, M.; Córdoba-Díaz, D. The Effect of Photodegradation on the Fluorescent Properties of Norfloxacin: (Photodegradation and Fluorescence of Norfloxacin). J. Pharm. Biomed. Anal. 1998, 18(4–5), 865–870.
  • Cox, C. E. Oral Norfloxacin versus Parenteral Treatment of Nosocomial Urinary Tract Infection. Am. J. Med. 1987, 82(6 Suppl. 2), 59–64.
  • Darwish, I. A.; Sultan, M. A.; Al-Arfaj, H. A. Novel Selective Kinetic Spectrophotometric Method for Determination of Norfloxacin in Its Pharmaceutical Formulations. Talanta 2009, 78(4–5), 1383–1388.
  • Delon, A.; Bouquet, S.; Huguet, F.; Brunet, V.; Courtois, P.; Couet, W. Pharmacokinetic-Pharmacodynamic Contributions to the Convulsant Activity of Fluoroquinolones in Rats. Antimicrob. Agents Chemother. 1999, 43(6), 1511–1515.
  • Deng, B.; Su, C.; Kang, Y. Determination of Norfloxacin in Human Urine by Capillary Electrophoresis with Electrochemiluminescence Detection. Anal. Bional. Chem. 2006, 385(7), 1336–1341.
  • Domagala, J. M. Structure-Activity and Structure-Side-Effect Relationships for the Quinolone Antibacterials. J. Antimicrob. Chemother. 1994, 33(4), 685–706.
  • Du, L.; Xu, Q.; Yuan, J. Fluorescence Spectroscopy Determination of Fluoroquinolones by Charge-Transfer Reaction. J. Pharm. Biomed. Anal. 2003, 33(4), 693–698.
  • Du, L. M.; Yao H. Y.; Fu, M. Spectrofluorimetric Study of the Charge-Transfer Complexation of Certain Fluoroquinolones with 7,7,8,8-Tetracyanoquinodimethane. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2005, 61(1–2), 281–286.
  • El-Brashy, A. M.; El-Saved, M. M.; El-Sepai, F. A. Spectrophotometric Determination of Some Fluoroquinolone Antibacterials by Binary Complex Formation with Xanthene Dyes. Farmaco 2004b, 59(10), 809–817.
  • El-Brashy, A. M.; Metwally, M. E. S.; El-Sepai, F. A. Spectrophotometric and Atomic Absorption Spectroscopic Determination of Some Fluoroquinolone Antibacterials by Ion-Pair Complex Formation with Bismuth (III) Tetraiodide. J. Chin. Chem. Soc. 2005b, 52(2), 253–262.
  • El-Brashy, A. M.; Metwally, M. E. S.; El-Sepai, F. A. Spectrophotometric Determination of Some Fluoroquinolone Antibacterials by Ion-Pair Complex Formation with Cobalt (II) Tetrathiocyanate. J. Chin. Chem. Soc. 2005a, 52(1), 77–84.
  • El-Brashy, A. M.; Metwally, M. E. S.; El-Sepai, F. A. Spectrophotometric Determination of Some Fluoroquinolone Antibacterials through Charge-Transfer and Ion-Pair Complexation Reactions. Bull. Korean Chem. Soc. 2004a, 25(3), 365–372.
  • El-Khateeb, S. Z.; Razek, S. A. A.; Amer, M. M. Stability-Indicating Methods for the Spectrophotometric Determination of Norfloxacin. J. Pharm. Biomed. Anal. 1998, 17(4–5), 829–840.
  • El-Walily, A. F. M.; Belal, S. F.; Bakry, R. S. Spectrophotometric and Spectrofluorimetric Estimation of Ciprofloxacin and Norfloxacin by Ternary Complex Formation with Eosin and Palladium (II). J. Pharm. Biomed. Anal. 1996, 14(5), 561–569.
  • Espinosa-Mansilla, A.; Peña, A. M.; Gómez, D. G.; López, F. S. Determination of Fluoroquinolones in Urine and Serum by Using High Performance Liquid Chromatography and Multiemission Scan Fluorimetric Detection. Talanta 2006, 68(4), 1215–1221.
  • Espinosa-Mansilla, A.; Peña, A. M.; Gómez, D. G.; Salinas, F. HPLC Determination of Enoxacin, Ciprofloxacin, Norfloxacin and Ofloxacin with Photoinduced Fluorimetric (PIF) Detection and Multi Emission Scanning: Application to Urine and Serum. J. Chromatogr. B 2005, 822(1–2), 185–193.
  • European Pharmacopoeia, 7th ed.; European Directorate for the Quality of Medicines, Council of Europe: Strasbourg, France, 2011.
  • Farmacopéia Brasileira, 4th ed.; Atheneu: São Paulo, Brazil, 2001; Supl. 2001; p 164.
  • Farmacopeia Portuguesa, 8th ed.; Tipografia Peres: Lisbon, 2005; Vol. 2; p 2578.
  • Ferdig, M.; Keleta, A.; Vo, T. D.; Buchberger, W. Improved Capillary Electrophoretic Separation of Nine (Fluoro)quinolones with Fluorescence Detection for Biological and Environmental Samples. J. Chromatogr. A 2004, 1047(2), 305–311.
  • Fierens, C.; Hillaert, S.; Van DenBossche, W. The Qualitative and Quantitative Determination of Quinolones of First and Second Generation by Capillary Electrophoresis. J. Pharm. Biomed. Anal. 2000, 22(5), 763–772.
  • Fitton, A. The Quinolones. An Overview of Their Pharmacology. Clin. Pharmacokinet. 1992, 22(1 Suppl. 1), 1–11.
  • Forchetti, C.; Flammini, D.; Carlucci, G.; Cavicchio, G.; Vaggi, L.; Bologna, M. High-Performance Liquid Chromatographic Procedure for the Quantitation of Norfloxacin in Urine, Serum and Tissues. J. Chromatogr. 1984, 309, 177–182.
  • Froehlich, P. E.; Schapoval, E. E. S. Doseamento físico-químico do norfloxacino espectrofotometria no ultravioleta. Braz. J. Pharm. Sci. 1990c, 12, 167–170.
  • Froehlich, P. E.; Schapoval, E. E. S. Doseamento físico-químico do norfloxacino método espectrofotométrico do reativo de Marquis. Braz. J. Pharm. Sci. 1990b, 12, 177–182.
  • Froelich, P. E.; Schapoval, E. E. S. Doseamento microbiológico do norfloxacino: Método da difusão em ágar (cilindros em placas). Braz. J. Pharm. Sci. 1990a, 12, 161–165.
  • Froehlich, P. E.; Schapoval, E. E. S.; Bortolan, S. Doseamento físico-químico do norfloxacino: Método espectrofotométrico do cloreto de ferro III. Braz. J. Pharm. Sci. 1990, 12, 171–176.
  • Gadebusch, H. H.; Shungu, D. L. Norfloxacin, the First of a New Class of Fluoroquinolone Antimicrobials, Revisited. Int. J. Antimicrob. Agents 1991, 1, 3–28.
  • Gajda, A.; Posyniak, A.; Zmudzki, J.; Gbylik, M.; Bladek, T. Determination of (Fluoro)quinolones in Eggs by Liquid Chromatography with Fluorescence Detection and Confirmation by Liquid Chromatography-Tandem Mass Spectrometry. Food Chem. 2012, 135(2), 430–439.
  • Galarini, R.; Fioroni, L.; Angelucci, F.; Tovo, G. R.; Cristofani, E. Simultaneous Determination of Eleven Quinolones in Animal Feed by Liquid Chromatography with Fluorescence and Ultraviolet Absorbance Detection. J. Chromatogr. A 2009, 1216(46), 8158–8164.
  • Garey, K. W.; Amsden, G. W. Trovafloxacin: An Overview. Pharmacotherapy 1999, 19(1), 21–34.
  • Gauzit, R.; Lakdhari, M. Generic Antibiotic Drugs: Is Effectiveness Guaranteed? Med. Mal. Infect. 2012, 42(4), 141–148.
  • Gigosos, P. G.; Revesado, P. R.; Cadahía, O.; Fente, C. A.; Vazquez, B. I.; Franco, C. M.; Cepeda, A. Determination of Quinolones in Animal Tissues and Eggs by High-Performance Liquid Chromatography with Photodiode-Array Detection. J. Chromatogr. A 2000, 871(1–2), 31–36.
  • Goldstein, E. J. C. Norfloxacin, a Fluoroquinolone Antibacterial Agent: Classification, Mechanism of Action, and in Vitro Activity. Am. J. Med. 1987, 82(6 Suppl. 2), 3–17.
  • Gowda, B. G.; Seetharamappa, J. Extractive Spectrophotometric Determination of Fluoroquinolones and Antiallergic Drugs in Pure and Pharmaceutical Formulations. Anal. Sci. 2003, 19(3), 461–464.
  • Grangie, J. D.; Roulot, D.; Pelletier, G.; Pariente, E. A.; Denis, J.; Ink O.; Blanc, P.; Richardet, J. P.; Vinel, J. P.; Delisle, F.; Fischer, D.; Flahault, A.; Amiot, X. Norfloxacin Primary Prophylaxis of Bacterial Infections in Cirrhotic Patients with Ascites: A Double-Blind Randomized Trial. J. Hepatol. 1998, 29(3), 430–436.
  • Groeneveld, A. J. N.; Brouwers, J. R. B. J. Quantitative Determination of Ofloxacin, Ciprofloxacin, Norfloxacin and Pefloxacin in Serum by High Pressure Liquid Chromatography. Pharm. Weekbl. Sci. 1986, 8(1), 79–84.
  • Hawkey, P. M. Mechanisms of Quinolone Action and Microbial Response. J. Antimicrob. Chemother. 2003, 51(Suppl. 1), 29–35.
  • Hayashi, N.; Nakata, Y.; Yazaki, A. New Findings on the Structure-Phototoxicity Relationship and Photostability of Fluoroquinolones with Various Substituents at Position 1. Antimicrob. Agents Chemother. 2004, 48(3), 799–803.
  • Hernández, M.; Borrull, F.; Calull, M. Determination of Quinolones in Plasma Samples by Capillary Electrophoresis Using Solid-Phase Extraction. J. Chromatogr. B 2000, 742(2), 255–265.
  • Higgins, N. P.; Peebles, C. L.; Sugino, A.; Cozzarelli, N. R. Purification of Subunits of Escherichia coli DNA Gyrase and Reconstitution pf Enzymatic Activity. Proc. Natl. Acad. Sci. 1978, 75(4), 1773–1777.
  • Hooper, D. C. Mode of Action of Fluoroquinolones. Drugs 1999, 58(Suppl. 2), 6–10.
  • Hussain, M. S.; Chukwumaeze-Obiajunwa, V.; Micetich, R. G. Sensitive High-Performance Liquid Chromatographic Assay for Norfloxacin Utilizing Fluorescence Detection. J. Chromatogr. B 1995, 663(2), 379–384.
  • International Conference on Harmonization. Validation of Analytical Procedures: Text and Methodology Q2(R1); International Conference on Harmonization: Geneva, Switzerland, 2005.
  • Izawa, A.; Kisaki, Y.; Irie, K.; Eda, Y.; Nakagome, T.; Komatsu T. Antibacterial Activity of Miloxacin. Antimicrob. Agents Chemother. 1980, 18(1), 37–40.
  • Jones, R. N.; Andes, D. R.; Mandell, L. A.; Gothelf, S.; Ehrhardt, A. F.; Nicholson, S. C. Gatifloxacin Used for Therapy of Outpatient Community-Acquired Pneumonia Caused by Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 2002, 44(1), 93–100.
  • Jones, R. N.; Mandell, L. A. Fluoroquinolones for the Treatment of Outpatient Community-Acquired Pneumonia. Diagn. Microbiol. Infect. Dis. 2002, 44(1), 69–76.
  • Just, P. M. Overview of the Fluoroquinolones Antibiotics. Pharmacotherapy 1993, 13(2), 4–17.
  • Kassab, N. M.; Singh, A. K.; Kedor-Hackmam, E. R. M.; Santoro, M. I. R. M. Quantitative Determination of Ciprofloxacin and Norfloxacin in Pharmaceutical Preparations by High Performance Liquid Chromatography. Braz. J. Pharm. Sci. 2005, 41(4), 507–513.
  • Khan, G. A.; Lindberg, R.; Grabic, R.; Fick, J. The Development and Application of a System for Simultaneously Determining Anti-infectives and Nasal Decongestants Using On-Line Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2012, 66, 24–32.
  • King, D. E.; Malone, R.; Lilley, S. H. New Classification and Update on the Quinolone Antibiotics. Am. Fam. Physician 2000, 61(9), 2741–2748.
  • Kowalski, P.; Oledzka, I.; Lamparczyk, H. Capillary Electrophoresis in Analysis of Veterinary Drugs. J. Pharm. Biomed. Anal. 2003, 32(4-5), 937–947.
  • Laganà, A.; Curini, R.; D’Ascenzo, G.; Marino, A.; Rotatori, M. High-Performance Liquid Chromatographic Determination of Norfloxacin in Human Tissues and Plasma with Fluorescence Detection. J. Chromatogr. 1987, 417, 135–142.
  • Laganà, A.; Marino, A.; Rotatori, M.; Curini, R.; D’Ascenzo, G.; Miano, L. High-Performance Liquid Chromatographic Analysis of Norfloxacin in Human Tissues and Plasma with Fluorescence Detection. J. Pharm. Biomed. Anal. 1988, 6(3), 221–228.
  • Lee, C.; Ronald, A. R. Norfloxacin: Its Potential in Clinical Practice. Am. J. Med. 1987, 82(6 Suppl. 2), 27–34.
  • Lee, D. S.; Han, H. J.; Kim, K.; Park, W. B.; Cho, J. K.; Kim, J. H. Dissociation and Complexation of Fluoroquinolone Analogues. J. Pharm. Biomed. Anal. 1994, 12(2), 157–164.
  • Lee, H. B.; Peart, T. E.; Svoboda, M. L. Determination of Ofloxacin, Norfloxacin, and Ciprofloxacin in Sewage by Selective Solid-Phase Extraction, Liquid Chromatography with Fluorescence Detection, and Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. A 2007, 1139(1), 45–52.
  • Lillenberg, M.; Yurchenko, S.; Kipper, K.; Herodes, K.; Pihl, V.; Sepp, K.; Lõhmus, R.; Nei, L. Simultaneous Determination of Fluoroquinolones, Sulfonamides and Tetracyclines in Sewage Sludge by Pressurized Liquid Extraction and Liquid Chromatography Electrospray Ionization-Mass Spectrometry. J. Chromatogr. A 2009, 1216(32), 5949–5954.
  • Lin, C. E.; Deng, Y., Jr.; Liao, W. S.; Sun, S. W.; Lin, W. Y.; Chen, C. C. Electrophoretic Behavior and pKa Determination of Quinolones with a Piperazinyl Substituent by Capillary Zone Electrophoresis. J. Chromatogr. A 2004, 1051(1–2), 283–290.
  • Liu, P.; Muller, M.; Derendorf, H. Rational Dosing of Antibiotics: The Use of Plasma Concentrations versus Tissue Concentrations. Int. J. Antimicrob. Agents 2002, 19(4), 285–290.
  • Liu, Y. M.; Cao, J. T.; Wang, H. Capillary Electrophoresis with Electrochemiluminescence Detection for the Analysis of Quinolone Drugs and Pharmacokinetics Study. Chin. Chem. Lett. 2008, 19(8), 962–964.
  • Lombardo-Aqui, M.; Gámiz-Gracia, L.; Gracia-Campaña, A. M.; Cruces-Blanco, C. Sensitive Determination of Fluoroquinolone Residues in Waters by Capillary Electrophoresis with Laser-Induced Fluorescence Detection. Anal. Bioanal. Chem. 2010, 396(4), 1551–1557.
  • Marona, H. R.; Schapoval, E. E. Spectrophotometric Determination of Sparfloxacin in Pharmaceutical Formulations Using Bromothymol Blue. J. Pharm. Biomed. Anal. 2001, 26(3), 501–504.
  • Mascher, H. J.; Kikuta, C. Determination of Norfloxacin in Human Plasma and Urine by High-Performance Liquid Chromatography and Fluorescence Detection. J. Chromatogr. A 1998, 812(1–2), 381–385.
  • McCourt, J.; Bordim, G.; Rodrígues, A. R. Development of a Capillary Zone Electrophoresis-Electrospray Ionisation Tandem Mass Spectrometry Method for the Analysis of Fluoroquinolone Antibiotics. J. Chromatogr. A 2003, 990(1–2), 259–269.
  • Mitani, K.; Kataoka, H. Determination of Fluoroquinolones in Environmental Waters by In-Tube Solid-Phase Microextraction Coupled with Liquid Chromatography-Tandem Mass Spectrometry. Anal. Chim. Acta 2006, 562(1), 16–22.
  • Moellering, R. C. Norfloxacin: A Fluoroquinolone Carboxylic Acid Antimicrobial Agent. Am. J. Med. 1987, 82(6 Suppl. 6), 1–2.
  • Moema, D.; Nindi, M. M.; Dube, S. Development of a Dispersive Liquid-Liquid Microextraction Method for the Determination of Fluoroquinolones in Chiken Liver by High Performance Liquid Chromatography. Anal. Chim. Acta 2012, 730, 80–86.
  • Montay, G.; Tassel, J. P. Improved High-Performance Liquid Chromatographic Determination of Pefloxacin and Its Metabolite Norfloxacin in Human Plasma and Tissue. J. Chromatogr. B 1985, 339, 214–218.
  • More, V. R.; Mote, U. S.; Patil, S. R.; Kolekar, G. B. Spectroscopic Studies on the Interaction between Norfloxacin and p-Amino Benzoic Acid: Analytical Application on Determination of Norfloxacin. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2009, 74(3), 771–775.
  • Morton, S. J.; Shull, V. H.; Dick, J. D. Determination of Norfloxacin and Ciprofloxacin Concentrations in Serum and Urine by High-Pressure Liquid Chromatography. Antimicrob. Agents Chemother. 1986, 30(2), 325–327.
  • Mouton, J. W.; Dudley, M. N.; Cars, O.; Derendorf, H.; Drusano, G. L. Standardization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Terminology for Anti-Infective Drugs: An Update. J. Antimicrob. Chemother. 2005, 55(5), 601–607.
  • Musa, K. A. K.; Eriksson, L. A. Theoretical Assessment of Norfloxacin Redox and Photochemistry. J. Phys. Chem. A 2009, 113(40), 10803–10810.
  • Naik, P. N.; Chimatadar, S. A.; Nandibewoor, S. T. Kinetics and Oxidation of Fluoroquinolone Antibacterial Agent, Norfloxacin, by Alkaline Permanganate: A Mechanistic Study. Ind. Eng. Chem. Res. 2009, 48(5), 2548–2555.
  • Naumann, P.; Dopp, C. Fluoroquinolones Antibacterial Activity, Pharmacokinetics and Indications for a New Group of Chemotherapeutic Drugs. Internist (Berl.) 1989, 30(1), 20–31.
  • Nilsson-Ehle, I. Assay of Ciprofloxacin and Norfloxacin in Serum and Urine by High Performance Liquid Chromatography. J. Chromatogr. 1987, 416(1), 207–211.
  • Oliphant, C. M.; Green, G. M. Quinolones: A Comprehensive Review. Am. Fam. Physician 2002, 65(3), 455–465.
  • Oliveira, P. R.; Bernardi, L. S.; Mendes, C.; Cardoso, S. G.; Sangoi, M. S.; Silva, M. A. S. Liquid Chromatographic Determination of Norfloxacin in Extended-Release Tablets. J. Chromatogr. Sci. 2009, 47(9), 739–744.
  • O’Neil, M. J., Ed. The Merck Index. 14th ed.; Merck: Whitehouse Station, NJ, 2006.
  • Patel, P.; Patel, K.; Bhatt, K. K.; Patel, S. New Improved RP-HPLC Method for Determination of Norfloxacin and Ornidazole in Their Combined Dosage Form. Int. J. Res. Pharm. Biomed. Sci. 2011, 2(2), 710–713.
  • Payán, M. R.; López, M. A. B.; Torres, R. F.; González, J. A. O.; Mochón, M. C. Hollow Fiber-Based Liquid Phase Microextraction (HF-LPME) as a New Approach for the HPLC Determination of Fluoroquinolones in Biological and Environmental Matrices. J. Pharm. Biomed. Anal. 2011, 55(2), 332–341.
  • Pecorelli, I.; Galarini, R.; Bibi, R.; Floridi, Al.; Casciarri, E.; Floridi, A. Simultaneous Determination of 13 Quinolones from Feeds Using Accelerated Solvent Extraction and Liquid Chromatography. Anal. Chim. Acta 2003, 483(1–2), 81–89.
  • Pojanagaroon, T.; Watanesk, S.; Rattanaphani, V.; Liawrungrath, S. Reverse Flow Injection Spectrophotometric Determination of Iron(III) Using Norfloxacin. Talanta 2002, 58(6), 1293–1300.
  • Qin, W.; Liu, Q.; Fan, Y. CE Determination of Quinolones in the Presence of Bovine Serum Albumin. J. Sep. Sci. 2009, 32(1), 118–124.
  • Ragab, G. H.; Amin, A. S. Atomic Absorption Spectroscopic, Conductometric and Colorimetric Methods for Determination of Fluoroquinolone Antibiotics Using Ammonium Reineckate Ion-Pair Complex Formation. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2004, 60, 973–978.
  • Rahman, N.; Ahmad, Y.; Hejaz-Azmi, S. N. Kinetic Spectrophotometric Method for the Determination of Norfloxacin in Pharmaceutical Formulations. Eur. J. Pharm. Biopharm. 2004, 57(2), 359–367.
  • Ramirez-Ronda, C.; Colon, M.; Saavedra, S.; Sabbaj, J.; Corrado, M. L. Treatment of Urinary Tract with Norfloxacin: Analysis of Cost. Am. J. Med. 1987, 82(6 Suppl. 2), 75–78.
  • Rao, R. N.; Nagaraju, V. Separation and Determination of Synthetic Impurities of Norfloxacin by Reversed-Phase High Performance Liquid Chromatography. J. Pharm. Biomed. Anal. 2004, 34(5), 1049–1056.
  • Refat, M. S.; El-Falaky, A.; Elesh, E. Spectroscopic and Physical Measurements on Charge-Transfer Complex: Interactions between Norfloxacin and Ciprofloxacin Drugs with Picric Acid and 3,5-Dinitrobenzoic Acid Acceptors. J. Mol. Struct. 2011, 990(1–3), 217–226.
  • Robson, R. A. Quinolone Pharmacokinetics. Int. J. Antimicrob. Agents 1992, 2(1), 3–10.
  • Roner, M. R.; Carraher, C. E.; Roehr, J. L.; Bassett, K. D.; Siegmannlouda, D. W. Anti-viral Activity of Norfloxacin and Ampicillin and Dibutyltin Polymers Derived from Norfloxacin and Ampicillin against Reovirus ST3, Vaccine Virus, Herpes Simplex Virus (HSV-1) and Varicela Zoster Virus (VZV). Polym. Mater. Sci. 2004, 91, 744–746.
  • Rufino, J. L.; Pezza, H. R.; Pezza, L.; Pinto, P. C. A. G.; Saraiva, M. L. M. F. S.; Lima, J. L. F. C. Sequential Injection Analysis System with Spectrophotometric Detection for Determination of Norfloxacin and Ciprofloxacin in Pharmaceutical Formulations. Quim. Nova 2011, 34(2), 256–261.
  • Salem, H. Spectrofluorimetric, Atomic Absorption Spectrometric and Spectrophotometric Determination of Some Fluoroquinolones. Am. J. Sci. 2005, 2(3), 719–729.
  • Sarro, A. D.; Sarro, G. D. Adverse Reaction to Fluoroquinolones. An Overview on Mechanistic Aspects. Curr. Med. Chem. 2001, 8(4), 371–384.
  • Sastry, C. S.; Rao, K. R.; Prasad, D. S. Extractive Spectrophotometric Determination of Some Fluoroquinolone Derivatives in Pure and Dosage Forms. Talanta 1995, 42(3), 311–316.
  • Schaeffer, A. J. Multiclinic Study of Norfloxacin for Treatment of Urinary Tract Infections. Am. J. Med. 1987, 82(6 Suppl. 2), 53–58.
  • Schmitt-Kopplin, P.; Burhenne, J.; Freitag, D.; Spiteller, M.; Kettrup, A. Development of Capillary Electrophoresis Methods for the Analysis of Fluoroquinolones and Application to the Study of the Influence of Humic Substances on Their Photodegradation in Aqueous Phase. J. Chromatogr. A 1999, 837(1–2), 253–265.
  • Sebaiy, M. M.; El-shanawany, A.; El-adl, S. M.; Abdel-aziz, L. M.; Hashem, H. A. Rapid RP-HPLC Method for Simultaneous Estimation of Norfloxacin and Tinidazole in Tablet Dosage Form. Asian J. Pharm. Anal. 2011, 1(4), 79–84.
  • Segreti, J.; Jones, R. N.; Bertino, Jr., J. S. Challenges in Assessing Microbial Susceptibility and Predicting Clinical Response to Newer-Generation Fluoroquinolones. J. Ocul. Pharmacol. Ther. 2012, 28(1), 3–11.
  • Shabir, G. A. Validation of High-Performance Liquid Chromatography Methods for Pharmaceutical Analysis: Understanding the Differences and Similarities between Validation Requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J. Chromatogr. A 2003, 987(1–2), 57–66.
  • Shaikh, A. R.; Giridhar, R.; Yadav, M. R. Bismuth-Norfloxacin Complex: Synthesis, Physicochemical and Antimicrobial Evaluation. Int. J. Pharm. 2007, 332(1–2), 24–30.
  • Shao, B.; Chen, D.; Zhang, J.; Wu, Y.; Sun C. Determination of 76 Pharmaceutical Drugs by Liquid Chromatography-Tandem Mass Spectrometry in Slaughterhouse Wastewater. J. Chromatogr. A 2009, 1216(47), 8312–8318.
  • Sharma, P. C.; Saneja, A.; Jain, S. Norfloxacin: A Therapeutic Review. Int. J. Chem. Sci. 2008, 6(4), 1702–1713.
  • Shen, L. L.; Bures, M. G.; Chu, D. T. W.; Plattner, J. J. Quinolone-DNA Interaction: How a Small Drug Molecule Acquires High DNA Binding Affinity and Specificity. Jerusalem Symp. Quantum Chem. Biochem. 1990, 23, 495–512.
  • Shen, L. L.; Pernet, A. G. Mechanism of Inhibition of DNA Gyrase by Analogues of Nalidixic Acid: The Target of the Drugs Is DNA. Proc. Natl. Acad. Sci. 1985, 82(2), 307–311.
  • Sher, M.; Hussain, M. A.; Mehmood, M. H.; Hassan, M. N.; Bashir, S. Bioequivalence of Norfloxacin by HPLC-UV Method. J. Chil. Chem. Soc. 2010, 55(2), 203–205.
  • Shervington, L. A.; Abba, M.; Hussain, B.; Donnelly, J. The Simultaneous Separation and Determination of Five Quinolone Antibiotics Using Isocratic Reversed-Phase HPLC: Application to Stability Studies on an Ofloxacin Tablet Formulation. J. Pharm. Biomed. Anal. 2005, 39(3–4), 769–775.
  • Simonovska, B.; Andrensek, S.; Vovk, I.; Prosek, M. High-Performance Thin-Layer Chromatography Method for Monitoring Norfloxacin Residues on Pharmaceutical Equipment Surfaces. J. Chromatogr. A 1999, 862(2), 209–215.
  • Solangi, A. R.; Memon, S. Q.; Mallah, A.; Khuhawar, M. Y.; Bhanger, M. I. Quantitative Separation of Oxytocin, Norfloxacin and Diclofenac Sodium in Milk Samples Using Capillary Electrophoresis. Biomed. Chromatogr. 2009, 23(9), 1007–1013.
  • Souza, J.; Alves, G.; Fortuna, A.; Falcão, A. Analytical Methods for Determination of New Fluoroquinolones in Biological Matrices and Pharmaceutical Formulations by Liquid Chromatography: A Review. Anal. Bioanal. Chem. 2012, 403, 93–129.
  • Stein, G. E. Pharmacokinetics and Pharmacodynamics of Newer Fluoroquinolones. Clin. Infect. Dis. 1996, 23(Suppl. 1), 19–24.
  • Sturini, M.; Speltini, A.; Maraschi, F.; Rivagli, E.; Profumo, A. Solvent-Free Microwave-Assisted Extraction of Fluoroquinolones from Soil and Liquid Chromatography-Fluorescence Determination. J. Chromatogr. A 2010, 1217, 7316–7322.
  • Sun, S. W.; Chen, L. Y. Optimization of Capillary Electrophoretic Separation of Quinolone Antibacterials Using the Overlapping Resolution Mapping Scheme. J. Chromatogr. A 1997, 766(1–2), 215–224.
  • Sun, S. W.; Wu, A. C. Determination of Fluoroquinolone Antibacterials in Pharmaceutical Formulations by Capillary Electrophoresis. J. Liq. Chromatogr. Relat. Technol. 1999, 22(2), 281–296.
  • Ulu, S. T. Spectrofluorimetric Determination of Fluoroquinolones in Pharmaceutical Preparations. Spectrochim. Acta A Mol. Biomed. Spectrosc. 2009, 72(1), 138–143.
  • United States Pharmacopeia, 36th rev.; United States Pharmacopeial Convention: Rockville, MD, 2013.
  • U.S. Food and Drug Administration. Drugs@FDA. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (accessed 6/6/14).
  • Van Oort, W. J.; Sorel, R. H. A.; Brussee, D.; Schulman, S. G.; Zuman, P.; Den Hartigh, J. Polarographic Reduction and Determination of Nalidixic Acid. Anal. Chim. Acta 1983, 149, 175–191.
  • Vázquez, M. M. P.; Vazquez, P. P.; Galera, M. M.; Garcia, M. D. G. Determination of Eight Fluoroquinolones in Groundwater Samples with Ultrasound-Assisted Ionic Liquid Dispersive Liquid-Liquid Microextraction prior to High-Performance Liquid Chromatography and Fluorescence Detection. Anal. Chim. Acta 2012, 748, 20–27.
  • Vijan, L. E.; Conci, M. Absorption Study of Norfloxacin–DNA interaction. Macromol. Symp. 2008, 265(1), 260–267.
  • Vílchez, J. L.; Ballesteros, O.; Taoufiki, J.; Sanchéz-Palencia, G.; Navalón, A. Determination of the Antibacterial Norfloxacin in Human Urine and Serum Samples by Solid-Phase Spectrofluorimetry. Anal. Chim. Acta 2001, 444(2), 279–286.
  • Wagenlehner, F. M. E.; Wullt, B.; Perletti, G. Antimicrobials in Urogenital Infections. Int. J. Antimicrob. Agents 2011, 38, 3–10.
  • Wallis, C. S.; Charles, B. G.; Gahan, L. R. Rapid and Economical High-Performance Liquid Chromatographic Method for the Determination of Norfloxacin in Serum Using a Microparticulate C18 Guard Cartridge. J. Chromatogr. B 1995, 674(2), 306–309.
  • Wan, G. H.; Cui, H.; Pan, Y. L.; Zheng, P.; Liu, L. J. Determination of Quinolones Residues in Prawn Using High-Performance Liquid Chromatography with Ce(IV)-Ru(bpy)32+-HNO3 Chemiluminescence Detection. J. Chromatogr. B 2006, 843, 1–9.
  • Wang, Y.; Baeyens, W. R.; Huang, C.; Fei, G.; He, L.; Ouyang, J. Enhanced Separation of Seven Quinolones by Capillary Electrophoresis with Silica Nanoparticles as Additive. Talanta 2009, 77(5), 1667–1674.
  • World Health Organization. Medicines: Quality Control. http://www.who.int/medicines/areas/quality_safety/quality_assurance/control/en/index.html (accessed 5/20/13).
  • Yamada, M.; Mochizuki, H.; Yamada, K.; Kawai, M.; Mashima, Y. Aqueous Humor Levels of Topically Applied Levofloxacin, Norfloxacin, and Lomefloxacin in the Same Human Eyes. J. Cataract. Refract. Surg. 2003, 29(9), 1771–1775.
  • Yan, H.; Wang, H.; Qin, X.; Liu, B.; Du, J. Ultrasound-Assisted Dispersive Liquid-Liquid Microextraction for Determination of Fluoroquinolones in Pharmaceutical Wastewater. J. Pharm. Biomed. Anal. 2011, 54(1), 53–57.
  • Yang, Z.; Wang, X.; Qin, W.; Zhao, H. Capillary Electrophoresis-Chemiluminescence Determination of Norfloxacin and Prulifloxacin. Anal. Chim. Acta 2008, 623(2), 231–237.
  • Zhanel, G.; Walkty, A.; Vercaigne, L.; Karlowsky, J. A.; Embil, J.; Gin, A. S.; Hoban, D. J. The New Fluoroquinolones: A Critical Review. Can. J. Infect. Dis. 1999, 10(3), 207–238.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.